Glucagon-like peptide 1 (GLP-1): a potent gut hormone with a possible therapeutic perspective
The DOI matches its Crossref record; 145 of the 146 references it cites were found in a registry or an index.
Abstract
Glucagon-like peptide 1 (GLP-1) is a physiological incretin hormone from the lower gastrointestinal tract, partially explaining the augmented insulin response after oral compared to intravenous glucose administration in normal humans. In addition, GLP-1 also lowers glucagon concentrations, slows gastric emptying, stimulates (pro)insulin biosynthesis, and reduces food intake upon intracerebroventricular administration in animals. Therefore, GLP-1 offers some interesting perspective for the treatment of type 2, and perhaps also for type 1 diabetic patients. The other incretin hormone, gastric inhibitory polypeptide (GIP), has lost almost all its activity in type-2 diabetic patients. In contrast, GLP-1 glucose-dependently stimulates insulin secretion in type-2 diabetic patients and exogenous administration of GLP-1 ([7-37] or [7-36 amide]) in doses elevating plasma concentrations to approximately three to four times physiological postprandial levels fully normalizes fasting hyperglycaemia and reduces postprandial glycaemic increments. Due to rapid proteolytic cleavage, which results in an inactive or even antagonistic fragment. GLP-1 [9-36 amide], and to rapid elimination, the half-life of GLP-1 is too short to maintain therapeutic plasma levels for sufficient periods by subcutaneous injections of the natural peptide hormone. Current research aims to characterize GLP-1 analogues with more suitable pharmacokinetic properties than the original peptide. Given the large amount of GLP-1 present in L cells, it also appears worthwhile to search for more agents that could 'mobilize' this endogenous pool of GLP-1.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GLP-1, a 30- or 31-amino-acid-long peptide hormone, is a gastrointestinal peptide secreted by the intestinal tract that potentiates insulin release and reduces glucagon’s concentration in physiological conditions (15, 16).”
From GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach (2023) · cites this paper as [16]
In the citing paper
“Besides lowering blood glucose and reducing weight (incredibly visceral fat), GLP-1R agonists can also lower blood pressure, improve blood lipid disorder, and reduce fatty liver (16, 140).”
From GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach (2023) · cites this paper as [16]
In the citing paper
“Besides lowering blood glucose and reducing weight (incredibly visceral fat), GLP-1R agonists can also lower blood pressure, improve blood lipid disorder, and reduce fatty liver (16, 140).”
From GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach (2023) · cites this paper as [16]
In the citing paper
“Besides lowering blood glucose and reducing weight (incredibly visceral fat), GLP-1R agonists can also lower blood pressure, improve blood lipid disorder, and reduce fatty liver (16, 140).”
From GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach (2023) · cites this paper as [16]
In the citing paper
“Besides lowering blood glucose and reducing weight (incredibly visceral fat), GLP-1R agonists can also lower blood pressure, improve blood lipid disorder, and reduce fatty liver (16, 140).”
From GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach (2023) · cites this paper as [16]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950
Glucagon-like peptide-1 7–36: a physiological incretin in man
Kreymann, B., Ghatei, M. A., Williams, G., & Bloom, S. R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91194-9 · Cited by 1,928
Nauck, M. A., Heimesaat, M. M., Orskov, C., Holst, J. J., Ebert, R., & Creutzfeldt, W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116186 · Cited by 1,651
Self-citationGlucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.
Flint, A., Raben, A., Astrup, A., & Holst, J. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci990 · Cited by 1,402
MENTLEIN, R., GALLWITZ, B., & SCHMIDT, W. E. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17986.x · Cited by 1,161
Kieffer, T. J., McIntosh, C. H., & Pederson, R. A. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628397 · Cited by 1,124
Tissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans
Ørskov, C., Rabenhøj, L., Wettergren, A., Kofod, H., & Holst, J. J. (1994) · Diabetes · doi:10.2337/diab.43.4.535 · Cited by 919
Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*
Perley, M. J., & Kipnis, D. M. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105685 · Cited by 917
Thorens, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8641 · Cited by 906
Mojsov, S., Weir, G. C., & Habener, J. F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112855 · Cited by 882
Deacon, C. F., Nauck, M. A., Toft-Nielsen, M., Pridal, L., Willms, B., & Holst, J. J. (1995) · Diabetes · doi:10.2337/diab.44.9.1126 · Cited by 878
Self-citationNAUCK, M. A., HOMBERGER, E., SIEGEL, E. G., ALLEN, R. C., EATON, R. P., EBERT, R., & CREUTZFELDT, W. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-2-492 · Cited by 874
Self-citationGutniak, M., Ørkov, C., Holst, J. J., Ahrén, B., & Efendić, S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262003 · Cited by 868
Biologically erodable microspheres as potential oral drug delivery systems
Mathiowitz, E., Jacob, J. S., Jong, Y. S., Carino, G. P., Chickering, D. E., Chaturvedi, P., Santos, C. A., Vijayaraghavan, K., Montgomery, S., Bassett, M., et al. (1997) · Nature · doi:10.1038/386410a0 · Cited by 823
Nauck, M. A., Niedereichholz, U., Ettler, R., Holst, J. J., Ørskov, C., Ritzel, R., & Schmiegel, W. H. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.5.e981 · Cited by 817
Self-citationScrocchi, L. A., Brown, T. J., Maclusky, N., Brubaker, P. L., Auerbach, A. B., Joyner, A. L., & Drucker, D. J. (1996) · Nature Medicine · doi:10.1038/nm1196-1254 · Cited by 793
Deacon, C. F., Johnsen, A. H., & Holst, J. J. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.3.7883856 · Cited by 792
Creutzfeldt, W. (1979) · Diabetologia · doi:10.1007/bf01225454 · Cited by 731
Truncated GLP-1 (proglucagon 78?107-amide) inhibits gastric and pancreatic functions in man
Wettergren, A., Schjoldager, B., Mortensen, P. E., Myhre, J., Christiansen, J., & Holst, J. J. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01316798 · Cited by 670
Glucagon‐like peptide‐1 cells in the gastrointestinal tract and pancreas of rat, pig and man
EISSELE, R., GÖKE, R., WILLEMER, S., HARTHUS, H. ‐., VERMEER, H., ARNOLD, R., & GÖKE, B. (1992) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1992.tb01464.x · Cited by 654
Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor
Bullock, B. P., Heller, R. S., & Habener, J. F. (1996) · Endocrinology · doi:10.1210/en.137.7.2968 · Cited by 618
Herrmann, C., Göke, R., Richter, G., Fehmann, H.-C., Arnold, R., & Göke, B. (2009) · Digestion · doi:10.1159/000201231 · Cited by 597
Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats
Tang-Christensen, M., Larsen, P. J., Goke, R., Fink-Jensen, A., Jessop, D. S., Moller, M., & Sheikh, S. P. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.271.4.r848 · Cited by 597
Holz IV, G. G., Kiihtreiber, W. M., & Habener, J. F. (1993) · Nature · doi:10.1038/361362a0 · Cited by 594
Exon duplication and divergence in the human preproglucagon gene
Bell, G. I., Sanchez-Pescador, R., Laybourn, P. J., & Najarian, R. C. (1983) · Nature · doi:10.1038/304368a0 · Cited by 593
Thorens, B., Porret, A., Bühler, L., Deng, S.-P., Morel, P., & Widmann, C. (1993) · Diabetes · doi:10.2337/diab.42.11.1678 · Cited by 558
Nauck, M. A. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.4.912 · Cited by 506
Self-citationWillms, B., Werner, J., Holst, J. J., Orskov, C., Creutzfeldt, W., & Nauck, M. A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550773 · Cited by 502
Self-citationØRSKOV, C., HOLST, J. J., KNUHTSEN, S., BALDISSERA, F. G. A., POULSEN, S. S., & NIELSEN, O. V. (1986) · Endocrinology · doi:10.1210/endo-119-4-1467 · Cited by 482
Wei, Y., & Mojsov, S. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01430-9 · Cited by 450
Gastric emptying and release of incretin hormones after glucose ingestion in humans.
Schirra, J., Katschinski, M., Weidmann, C., Schäfer, T., Wank, U., Arnold, R., & Göke, B. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118411 · Cited by 426
ØRSKOV, C., HOLST, J. J., & NIELSEN, O. V. (1988) · Endocrinology · doi:10.1210/endo-123-4-2009 · Cited by 396
Cellular composition of the human diabetic pancreas
Rahier, J., Goebbels, R. M., & Henquin, J. C. (1983) · Diabetologia · doi:10.1007/bf00251826 · Cited by 395
Attenuated GLP-1 secretion in obesity: cause or consequence
Ranganath, L. R., Beety, J. M., Morgan, L. M., Wright, J. W., Howland, R., & Marks, V (1996) · Gut · doi:10.1136/gut.38.6.916 · Cited by 394
Campos, R. V. (1994) · Endocrinology · doi:10.1210/en.134.5.2156 · Cited by 353
Creutzfeldt, W. O. C., Kleine, N., Willms, B., Ørskov, C., Holst, J. J., & Nauck, M. A. (1996) · Diabetes Care · doi:10.2337/diacare.19.6.580 · Cited by 330
Self-citationDeacon, C. F., Hughes, T. E., & Holst, J. J. (1998) · Diabetes · doi:10.2337/diabetes.47.5.764 · Cited by 321
Schmidt, W. E., Siegel, E. G., & Creutzfeldt, W. (1985) · Diabetologia · doi:10.1007/bf00291980 · Cited by 319
Elahi, D., McAloon-Dyke, M., Fukagawa, N. K., Meneilly, G. S., Sclater, A. L., Minaker, K. L., Habener, J. F., & Andersen, D. K. (1994) · Regulatory Peptides · doi:10.1016/0167-0115(94)90136-8 · Cited by 309
Ørskov, C., Poulsen, S. S., Mørten, M., & Holst, J. J. (1996) · Diabetes · doi:10.2337/diab.45.6.832 · Cited by 304
Deacon, C. F., Knudsen, L. B., Madsen, K., Wiberg, F. C., Jacobsen, O., & Holst, J. J. (1998) · Diabetologia · doi:10.1007/s001250050903 · Cited by 303
Glucagon-like peptide-1, a new hormone of the entero-insular axis
Ørskov, C. (1992) · Diabetologia · doi:10.1007/bf00429088 · Cited by 293
A month–long effect from a single injection of microencapsulated human growth hormone
Johnson, O. L., Cleland, J. L., Lee, H. J., Charnis, M., Duenas, E., Jaworowicz, W., Shepard, D., Shahzamani, A., Jones, A. J. S., & Putney, S. D. (1996) · Nature Medicine · doi:10.1038/nm0796-795 · Cited by 292
Insulinotropic Action of Glucagonlike Peptide-I-(7–37) in Diabetic and Nondiabetic Subjects
Nathan, D. M., Schreiber, E., Fogel, H., Mojsov, S., & Habener, J. F. (1992) · Diabetes Care · doi:10.2337/diacare.15.2.270 · Cited by 289
Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM
Nauck, M. A., Wollschläger, D., Werner, J., Holst, J. J., Ørskov, C., Creutzfeldt, W., & Willms, B. (1996) · Diabetologia · doi:10.1007/s001250050613 · Cited by 285
Self-citationRoberge, J. N. (1993) · Endocrinology · doi:10.1210/en.133.1.233 · Cited by 276
Rachman, J., Barrow, B. A., Levy, J. C., & Turner, R. C. (1997) · Diabetologia · doi:10.1007/s001250050664 · Cited by 269
Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1
Gromada, J., Holst, J. J., & Rorsman, P. (1998) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s004240050558 · Cited by 258
Glucagonlike peptide 1: a newly discovered gastrointestinal hormone
Holst, J. J. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90831-1 · Cited by 252
Moens, K., Heimberg, H., Flamez, D., Huypens, P., Quartier, E., Ling, Z., Pipeleers, D., Gremlich, S., Thorens, B., & Schuit, F. (1996) · Diabetes · doi:10.2337/diab.45.2.257 · Cited by 250
Rouillé, Y., Martin, S., & Steiner, D. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26488 · Cited by 245
Role of prohormone convertases in the tissue-specific processing of proglucagon
Dhanvantari, S. (1996) · Molecular Endocrinology · doi:10.1210/me.10.4.342 · Cited by 242
Mammalian pancreatic preproglucagon contains three glucagon-related peptides.
Lopez, L. C., Frazier, M. L., Su, C. J., Kumar, A., & Saunders, G. F. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.18.5485 · Cited by 234
Glucagonostatic and Insulinotropic Action of Glucagonlike Peptide I-(7–36)-Amide
Komatsu, R., Matsuyama, T., Namba, M., Watanabe, N., Itoh, H., Kono, N., & Tarui, S. (1989) · Diabetes · doi:10.2337/diab.38.7.902 · Cited by 234
Navarro, M., De Fonseca, F. R., Alvarez, E., Chowen, J. A., Zueco, J. A., Gomez, R., Eng, J., & Blázquez, E. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67051982.x · Cited by 233
Layer, P., Juul Holst, J., Grandt, D., & Goebell, H. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02064202 · Cited by 216
Complete Sequences of Glucagon-like Peptide-1 from Human and Pig Small Intestine
Orskov, C., Bersani, M., Johnsen, A. H., Højrup, P., & Holst, J. J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)51561-1 · Cited by 210
Pancreatic and intestinal processing of proglucagon in man
Ørskov, C., Holst, J. J., Poulsen, S. S., & Kirkegaard, P. (1987) · Diabetologia · doi:10.1007/bf00274797 · Cited by 210
Ritzel, R., �rskov, C., Holst, J. J., & Nauck, M. A. (1995) · Diabetologia · doi:10.1007/bf00401846 · Cited by 210
Self-citationReimer, R. A. (1996) · Endocrinology · doi:10.1210/en.137.9.3948 · Cited by 207
Glucagon-like peptide-1 is a physiological incretin in rat.
Wang, Z., Wang, R. M., Owji, A. A., Smith, D. M., Ghatei, M. A., & Bloom, S. R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117671 · Cited by 190
Gromada, J., Bokvist, K., Ding, W.-G., Holst, J. J., Nielsen, J. H., & Rorsman, P. (1998) · Diabetes · doi:10.2337/diab.47.1.57 · Cited by 189
Holz, G. G., Leech, C. A., & Habener, J. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.30.17749 · Cited by 188
Kolligs, F., Fehmann, H.-C., Göke, R., & Göke, B. (1995) · Diabetes · doi:10.2337/diab.44.1.16 · Cited by 185
Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus
Shughrue, P. J. (1996) · Endocrinology · doi:10.1210/en.137.11.5159 · Cited by 182
Balks, H. J., Holst, J. J., Mühlen, A. V. Z., & Brabant, G. E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3816 · Cited by 179
Schjoldager, B. T. G., Mortensen, P. E., Christiansen, J., �rskov, C., & Holst, J. J. (1989) · Digestive Diseases and Sciences · doi:10.1007/bf01540341 · Cited by 178
Gut hormones and diabetes mellitus
Creutzfeldt, W., & Nauck, M. (1992) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610080206 · Cited by 176
Self-citationIdentification and Localization of Glucagon-Like Peptide-1 and Its Receptor in Rat Brain*
SHIMIZU, I., HIROTA, M., OHBOSHI, C., & SHIMA, K. (1987) · Endocrinology · doi:10.1210/endo-121-3-1076 · Cited by 174
Qualmann, C., Nauck, M. A., Holst, J. J., øSrskov, C., & Creutzfeldt, W. (1995) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529509101597 · Cited by 170
Self-citationGlucagon-Like Peptide I Reduces Postprandial Glycemic Excursions in IDDM
Dupré, J., Behme, M., Hramiak, I., McFarlane, P. G., Williamson, M., Zabel, P., & Mcdonald, T. (1995) · Diabetes · doi:10.2337/diab.44.6.626 · Cited by 169
Miholic, J., �rskov, C., Holst, J. J., Kotzerke, J., & Meyer, H.-J. (1991) · Digestive Diseases and Sciences · doi:10.1007/bf01296800 · Cited by 163
Wettergren, A., Wøjdemann, M., Meisner, S., Stadil, F., & Holst, J. J. (1997) · Gut · doi:10.1136/gut.40.5.597 · Cited by 153
Potent glycogenic effect of GLP-1(7?36)amide in rat skeletal muscle
Villanueva-Pe�acarrillo, M. L., Alc�ntara, A. I., Clemente, F., Delgado, E., & Valverde, I. (1994) · Diabetologia · doi:10.1007/bf00418382 · Cited by 152
Tseng, C. C., Kieffer, T. J., Jarboe, L. A., Usdin, T. B., & Wolfe, M. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119060 · Cited by 151
Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for Type 2-diabetes
Nauck, M. A., Holst, J. J., Willms, B., & Schmiegel, W. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1211750 · Cited by 145
Self-citationÅhrén, B., Larsson, H., & Holst, J. J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3728 · Cited by 145
Gutniak, M. K., Linde, B., Holst, J. J., & Efendić, S. (1994) · Diabetes Care · doi:10.2337/diacare.17.9.1039 · Cited by 139
Beak, S. A., Heath, M. M., Small, C. J., Morgan, D. G., Ghatei, M. A., Taylor, A. D., Buckingham, J. C., Bloom, S. R., & Smith, D. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci610 · Cited by 133
Wettergren, A., Petersen, H., ørskov, C., Christiansen, J., Sheikh, S. P., & Holst, J. J. (1994) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529409092462 · Cited by 133
Göke, B., Fuder, H., Wieckhorst, G., Theiss, U., Stridde, E., Littke, T., Kleist, P., Arnold, R., & Lücker, P. W. (2009) · Digestion · doi:10.1159/000201282 · Cited by 132
Regulation of glucagon-like peptide-1 secretion from rat ileum by neurotransmitters and peptides
Herrmann-Rinke, C., Vöge, A., Hess, M., & Göke, B. (1995) · Journal of Endocrinology · doi:10.1677/joe.0.1470025 · Cited by 130
Varndell, I. M., Bishop, A. E., Sikri, K. L., Uttenthal, L. O., Bloom, S. R., & Polak, J. M. (1985) · Journal of Histochemistry & Cytochemistry · doi:10.1177/33.10.3900195 · Cited by 130
Seifarth, C., Bergmann, J., Holst, J. J., Ritzel, R., Schmiegel, W., & Nauck, M. A. (1998) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199806)15:6<485::aid-dia610>3.0.co;2-y · Cited by 127
Self-citationGromada, J., Dissing, S., Bokvist, K., Renström, E., Frøkjær-Jensen, J., Wulff, B. S., & Rorsman, P. (1995) · Diabetes · doi:10.2337/diab.44.7.767 · Cited by 125
GLP-1 does not acutely affect insulin sensitivity in healthy man
Ørskov, L., Holst, J. J., Møller, J., Ørskov, C., Møller, N., Alberti, K. G. M. M., & Schmitz, O. (1996) · Diabetologia · doi:10.1007/bf02658511 · Cited by 123
Associations of body composition with Type 2 diabetes mellitus
Han, T. S., Feskens, E. J. M., Lean, M. E. J., & Seidell, J. C. (1998) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199802)15:2<129::aid-dia535>3.0.co;2-2 · Cited by 123
Egan, J. M., Montrose‐Rafizadeh, C., Wang, Y., Bernier, M., & Roth, J. (1994) · Endocrinology · doi:10.1210/endo.135.5.7956929 · Cited by 121
Ebert, R., Unger, H., & Creutzfeldt, W. (1983) · Diabetologia · doi:10.1007/bf00257346 · Cited by 120
Rachman, J., Gribble, F. M., Barrow, B. A., Lévy, J., Buchanan, K. D., & Turner, R. C. (1996) · Diabetes · doi:10.2337/diab.45.11.1524 · Cited by 119
Patzelt, C., & Schiltz, E. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.16.5007 · Cited by 118
Rocca, A. S. (1995) · Endocrinology · doi:10.1210/en.136.12.5593 · Cited by 117
Qualmann, C., Nauck, M. A., Holst, J. J., �rskov, C., & Creutzfeldt, W. (1995) · Acta Diabetologica · doi:10.1007/bf00581038 · Cited by 111
Self-citationDumoulin, V. (1995) · Endocrinology · doi:10.1210/en.136.11.5182 · Cited by 111
Gromada, J., Ding, W.-G., Barg, S., Renström, E., & Rorsman, P. (1997) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s004240050431 · Cited by 110
Toft-Nielson, M.-B., Madsbad, S., & Holst, J. J. (1996) · Diabetes · doi:10.2337/diab.45.5.552 · Cited by 105
Tillil, H., Shapiro, E. T., Miller, M. A., Karrison, T., Frank, B. H., Galloway, J. A., Rubenstein, A. H., & Polonsky, K. S. (1988) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1988.254.3.e349 · Cited by 105
Kanse, S. M., Kreymann, B., Ghatei, M. A., & Bloom, S. R. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)81063-9 · Cited by 104
Potential Therapeutic Levels of Glucagon-Like Peptide I Achieved in Humans by a Buccal Tablet
Gutniak, M. K., Larsson, H., Heiber, S. J., Juneskans, O. T., Holst, J. J., & Ahrén, B. (1996) · Diabetes Care · doi:10.2337/diacare.19.8.843 · Cited by 99
Göke, R., Wagner, B., Fehmann, H. C., & Göke, B. (1993) · Research in Experimental Medicine · doi:10.1007/bf02576216 · Cited by 96
Influence of Gastric Inhibitory Polypeptide Antiserum on Glucose-Induced Insulin Secretion in Rats
EBERT, R., & CREUTZFELDT, W. (1982) · Endocrinology · doi:10.1210/endo-111-5-1601 · Cited by 93
Valverde, I., Mérida, E., Delgado, E., Trapote, M. A., & Villanueva‐Peñacarrillo, M. L. (1993) · Endocrinology · doi:10.1210/endo.132.1.8380388 · Cited by 93
Glucagon-like peptide-1 (7–36)-NH2: a physiological inhibitor of gastric acid secretion in man
O'Halloran, D. J., Nikou, G. C., Kreymann, B., Ghatei, M. A., & Bloom, S. R. (1990) · Journal of Endocrinology · doi:10.1677/joe.0.1260169 · Cited by 91
Lipolytic action of glucagon-like peptides in isolated rat adipocytes
Ruiz-Grande, C., Alarcón, C., Mérida, E., & Valverde, I. (1992) · Peptides · doi:10.1016/0196-9781(92)90134-o · Cited by 89
Wang, Y., Egan, J., Raygada, M. J., Nadiv, O., Roth, J., & Montrose‐Rafizadeh, C. (1995) · Endocrinology · doi:10.1210/en.136.11.4910 · Cited by 88
Glucagon‐like peptide‐1 (GLP‐1): a trial of treatment in non‐insulin‐dependent diabetes mellitus
TODD, J. F., WILDING, J. P. H., EDWARDS, C. M. B., KHAN, F. A., GHATEI, M. A., & BLOOM, S. R. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.1490691.x · Cited by 87
Distribution of GLP‐1 and PACAP receptors in human tissues
Wei, Y., & Mojsov, S. (1996) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.1996.42256000.x · Cited by 86
KAWAI, K., SUZUKI, S., OHASHI, S., MUKAI, H., OHMORI, H., MURAYAMA, Y., & YAMASHITA, K. (1989) · Endocrinology · doi:10.1210/endo-124-4-1768 · Cited by 85
Glucagon-like peptide-1 binding to rat hepatic membranes
Villanueva-Peñacarrillo, M. L., Delgado, E., Trapote, M. A., Alcántara, A., Clemente, F., Luque, M. A., Perea, A., & Valverde, I. (1995) · Journal of Endocrinology · doi:10.1677/joe.0.1460183 · Cited by 79
Lamari, Y., Boissard, C., Moukhtar, M. S., Jullienne, A., Rosselin, G., & Garel, J.-M. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00895-2 · Cited by 73
Intra-islet regulation of hormone secretion by glucagon-like peptide-1-(7--36) amide
Heller, R. S., & Aponte, G. W. (1995) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1995.269.6.g852 · Cited by 73
Beak, S. A. (1996) · Endocrinology · doi:10.1210/en.137.10.4130 · Cited by 71
Protein Kinase A-dependent Phosphorylation of GLUT2 in Pancreatic β Cells
Thorens, B., Dériaz, N., Bosco, D., DeVos, A., Pipeleers, D., Schuit, F., Meda, P., & Porret, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.14.8075 · Cited by 69
Physiological augmentation of amino acid-induced insulin secretion by GIP and GLP-I but not by CCK-8
Fieseler, P., Bridenbaugh, S., Nustede, R., Martell, J., Orskov, C., Holst, J. J., & Nauck, M. A. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.268.5.e949 · Cited by 68
Self-citationGromada, J., Rorsman, P., Dissing, S., & Wulff, B. S. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01070-u · Cited by 66
Mérida, E., Delgado, E., Molina, L., Villanueva‐Peñacarrillo, M. L., & Valverde, I. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.6.8263154 · Cited by 65
Wettergren, A., Maina, P., Boesby, S., & Holst, J. J. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709025098 · Cited by 65
Juntti-Berggren, L., Pigon, J., Karpe, F., Hamsten, A., Gutniak, M., Vignati, L., & Efendic, S. (1996) · Diabetes Care · doi:10.2337/diacare.19.11.1200 · Cited by 63
Nauck, M. A., Siemsglüss, J., Ørskov, C., & Holst, J. J. (1996) · PubMed · Cited by 61
Self-citationImmunohistochemical localization of glucagon-like peptide 1
Kauth, T., & Metz, J. (1987) · Histochemistry and Cell Biology · doi:10.1007/bf00500625 · Cited by 61
Hoyt, E. C., Lund, P. K., Winesett, D. E., Fuller, C. R., Ghatei, M. A., Bloom, S. R., & Ulshen, M. H. (1996) · Diabetes · doi:10.2337/diab.45.4.434 · Cited by 59
Göke, R., Larsen, P. J., Mikkelsen, J. D., & Sheikh, S. P. (1995) · Neuroendocrinology · doi:10.1159/000126997 · Cited by 57
Signal transmission after GLP-1(7-36)amide binding in RINm5F cells
Goke, R., Trautmann, M. E., Haus, E., Richter, G., Fehmann, H. C., Arnold, R., & Goke, B. (1989) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1989.257.3.g397 · Cited by 54
Suga, S., Kanno, T., Nakano, K., Takeo, T., Dobashi, Y., & Wakui, M. (1997) · Diabetes · doi:10.2337/diab.46.11.1755 · Cited by 51
Nauck, M., Holst, J., & Willms, B. (1997) · Hormone and Metabolic Research · doi:10.1055/s-2007-979067 · Cited by 51
Self-citationBritsch, S., Krippeit‐Drews, P., Lang, F. J. W., Gregor, M., & Drews, G. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1149 · Cited by 49
A role for central glucagon-like peptide-1 in temperature regulation
OʼShea, D., Gunn, I., Chen, X., Bloom, S., & Herbert, J. (1996) · NeuroReport · doi:10.1097/00001756-199602290-00035 · Cited by 47
Miholic, J., Ørskov, C., Holst, J. J., Kotzerke, J., & Pichlmayr, R. (1993) · Digestion · doi:10.1159/000201016 · Cited by 43
Suzuki, S., Kawai, K., Ohashi, S., Mukai, H., Murayama, Y., & Yamashita, K. (1990) · Diabetes · doi:10.2337/diab.39.11.1320 · Cited by 41
Comparison of the effect of GIP and GLP‐1 (7–36amide) on insulin release from rat pancreatic islets
SIEGEL, E. G., SCHULZE, A., SCHMIDT, W. E., & CREUTZFELDT, W. (1992) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1992.tb01820.x · Cited by 40
Hargrove, D. M., Nardone, N. A., Persson, L. M., Parker, J. C., & Stevenson, R. W. (1995) · Metabolism · doi:10.1016/0026-0495(95)90021-7 · Cited by 36
Miki, H., Namba, M., Nishimura, T., Mineo, I., Matsumura, T., Miyagawa, J., Nakajima, H., Kuwajima, M., Hanafusa, T., & Matsuzawa, Y. (1996) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(96)00032-8 · Cited by 35
Therapeutic potential of glucagon-like peptide 1 in type 2 diabetes.
Nauck, M. A. (1996) · PubMed · Cited by 35
Self-citationGLP-1 depolarizes the rat pancreatic β cell in a Na+-dependent manner
Kato, M., Ma, H.-T., & Tatemoto, K. (1996) · Regulatory Peptides · doi:10.1016/0167-0115(95)00164-6 · Cited by 26
Pridal, L., Ingwersen, S. H., Larsen, F. S., Holst, J. J., Adelhorst, K., & Kirk, O. (1995) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/0731-7085(95)01312-9 · Cited by 23
Glucagon-like peptide-1(7–36) amide and glycogen synthesis in the liver
Nakagawa, Y., Kawai, K., Suzuki, H., Ohashi, S., & Yamashita, K. (1996) · Diabetologia · doi:10.1007/bf02658516 · Cited by 21
Gerich, J. E. (1989) · Aufklärung und Einwilligung im Arztrecht, ESA · doi:10.1007/978-3-642-74255-2_10 · Cited by 20
Valverde, E., Rada, O., Burrell, M. A., Rovira, J., & Sesma, P. (1993) · Tissue and Cell · doi:10.1016/0040-8166(93)90004-5 · Cited by 19
Release of glucagon-like peptide 1 immunoreactivity from the perfused rat pancreas
Shima, K., Hirota, M., Ohboshi, C., Sato, M., & Nishino, T. (1987) · European Journal of Endocrinology · doi:10.1530/acta.0.1140531 · Cited by 19
Regulation of Islet Hormone Gene Expression by Incretin Hormones
Fehmann, H. C., Gherzi, R., & Göke, B. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1211395 · Cited by 14
Hargrove, D. M., Nardone, N. A., Persson, L. M., Andrews, K. M., Shepherd, K. L., Stevenson, R. W., & Parker, J. C. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90297-8 · Cited by 14
Toft-Nielsen, M.-B., HVIDBERG, A. D., Hilsted, J., Dige‐Petersen, H., & Holst, J. J. (1996) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199606)13:6<544::aid-dia129>3.0.co;2-x · Cited by 8
Islet Cell-populations in Obese Subjects and Type-2 (non-insulin-dependent) Diabetic-patients
Rahier, J., Ibrahim, M., & Channaoui, K. (1989) · Diabetologia · Cited by 4
b‐Cell receptors for glucagon/GLP‐1 exendin(9–39) in mouse islets
Kofod, H., Kirk, O., & Adelhorst, K. (1996) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.1996.39264000.x · Cited by 3
Cited by
Glucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
Self-citationGastrointestinal hormones and food intake
Strader, A. D., & Woods, S. C. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.10.043 · Cited by 447
Talsania, T., Anini, Y., Siu, S., Drucker, D. J., & Brubaker, P. L. (2005) · Endocrinology · doi:10.1210/en.2005-0473 · Cited by 306
“agonist (24), the truncated form of PYY remains biologically”
BackgroundGLP−1 receptor agonists for the treatment of obesity: Role as a promising approach
Wang, J.-Y., Wang, Q.-W., Yang, X.-Y., Yang, W., Li, D.-R., Jin, J.-Y., Zhang, H.-C., & Zhang, X.-F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1085799 · Cited by 248
“Frontiers in Endocrinology 02 GLP-1, a 30- or 31-amino-acid-long peptide hormone, is a gastrointestinal peptide secreted by the intestinal tract that potentiates insulin release and reduces glucagon’s concentration in physiological conditions (15, 16).”
BackgroundWhat do we know about the secretion and degradation of incretin hormones?
Deacon, C. F. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2004.06.007 · Cited by 241
Metadata
- Authors
- Nauck, M. A.
- Affiliations
- Universitätsklinikum Knappschaftskrankenhaus Bochum (DE)
- Corresponding author
- Nauck, M. A.
- ORCID
- Nauck, M. A.
- Venue
- Acta Diabetologica
- Published
- 1998-10-23
- Volume
- 35
- Issue
- 3
- Pages
- 117-129
- ISSN
- 0940-5429 (ISSN-L)
- 1432-5233
- OpenAlex
- W2079136334
- Cited by
- 94
- References
- 146
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 5 · 2023: 5 · 2022: 2 · 2021: 5 · 2020: 1 · 2019: 1 · 2017: 2 · 2015: 4 · 2014: 2 · 2013: 7 · 2012: 3
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Diabetologica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- glucagon-like peptide-1, incretins, type 2 diabetes, type 1 diabetes, insulin secretion, glucose-dependent insulinotropic polypeptide, GLP-1 analogues, pharmacokinetics, gastric emptying, dietary intake, gastrointestinal hormones, L cells, fasting hyperglycemia, postprandial blood glucose
- MeSH terms
- Animals, Cerebral Ventricles, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Feeding Behavior, Gastric Emptying, Glucagon, Glucose, Humans, Insulin, Models, Biological, Peptide Fragments, Proinsulin, Protein Precursors, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.